E. Mungo

发表

ERK is a Pivotal Player of Chemo-Immune-Resistance in Cancer

E. Gazzano, J. Kopecka, C. Riganti, 2019, International journal of molecular sciences.

Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

M. Donadelli, E. Gazzano, J. Kopecka, 2018, Journal of Experimental & Clinical Cancer Research.

Hyperglycemia Promotes Chemoresistance Through the Reduction of the Mitochondrial DNA Damage, the Bax/Bcl-2 and Bax/Bcl-XL Ratio, and the Cells in Sub-G1 Phase Due to Antitumoral Drugs Induced-Cytotoxicity in Human Colon Adenocarcinoma Cells

B. Rolando, S. Doublier, O. Bosco, 2018, Front. Pharmacol..

Emergence of ceftazidime/avibactam resistance in KPC-3-producing Klebsiella pneumoniae in vivo.

M. Hogardt, T. Wichelhaus, S. Besier, 2019, The Journal of antimicrobial chemotherapy.

Mitochondria-Targeted Doxorubicin: A New Therapeutic Strategy against Doxorubicin-Resistant Osteosarcoma

Shana O. Kelley, Silvia Deaglio, Ilaria Roato, 2016, Molecular Cancer Therapeutics.

Mitochondrial metabolism: Inducer or therapeutic target in tumor immune-resistance?

E. Gazzano, J. Kopecka, C. Riganti, 2020, Seminars in cell & developmental biology.

Pyruvate Treatment Restores the Effectiveness of Chemotherapeutic Agents in Human Colon Adenocarcinoma and Pleural Mesothelioma Cells

S. Doublier, L. Bergandi, E. Mungo, 2018, International journal of molecular sciences.

Mortality among female nurses in the face of the AIDS epidemic: a pilot study in Zambia.

A. Buvé, E. Mungo, S. D. Foaster, 1994, AIDS.

Increasing intratumor C/EBP-β LIP and nitric oxide levels overcome resistance to doxorubicin in triple negative breast cancer

M. Donadelli, E. Gazzano, J. Kopecka, 2018, Journal of experimental & clinical cancer research : CR.

Klebsiella pneumoniae: emergence of multi-drug-resistant strains in Northwest Italy.

M. G. Chirillo, D. Savoia, E. Mungo, 2012, The Journal of infection.